Life with DBS

Life with DBS

Life after Deep Brain Stimulation is not defined by the device itself, but by what the device allows patients to regain. For most individuals, the transition happens gradually. In the early weeks, there is recovery from surgery and the beginning of programming. Over time, as stimulation is refined and medications are adjusted, many patients begin to experience a more stable and predictable pattern of symptoms. What often changes is not just how the body feels, but how the day feels—less uncertainty, fewer interruptions, and more control.

A day before and after DBS: the swings between ON and OFF flatten out
A day before and after DBS: the swings between ON and OFF flatten out.

What changes day to day

For patients with Parkinson’s disease, this may mean fewer fluctuations between ON and OFF states, less time spent waiting for medications to take effect, and less disruption from dyskinesias. For those with essential tremor, it may mean the return of steady hands—being able to write legibly, eat without spilling, or hold a cup without hesitation. For patients with dystonia, improvement may come more gradually, but can include reduced pain, improved posture, and greater ease of movement. These changes are often most meaningful not in the clinic, but in everyday moments—meals, conversations, hobbies, and time with family.

Programming continues

DBS is not a one-time treatment that ends after surgery. It becomes part of ongoing care. Programming visits continue over time, especially in the first several months, as settings are adjusted to find the best balance between symptom control and side effects. Even after this initial period, periodic follow-up remains important. As underlying conditions evolve, the system can be reprogrammed to adapt. This flexibility is one of the defining strengths of DBS.

Medications after DBS

Most patients continue to take some medications after DBS, although doses are often reduced or simplified. The goal is not necessarily to eliminate medications entirely, but to use them more effectively alongside stimulation. Many patients find that their medication schedule becomes less burdensome and more predictable.

Living with the device

From a practical standpoint, the DBS system itself becomes familiar over time. The pulse generator, typically located in the chest, is designed to be low-profile. Patients are given a handheld controller that allows them to check the system and, in some cases, make limited adjustments within safe parameters set by their care team. Rechargeable systems require periodic charging—often once a week or less—while non-rechargeable systems last several years before needing replacement. Battery replacement is a relatively simple outpatient procedure.

Three companies make the deep brain stimulation systems available in the United States. All three are well established, and the differences that matter most are practical ones: how the battery is managed, what kind of MRI scan is possible afterwards, how settings are adjusted, and what the patient carries.

The three deep brain stimulation systems available in the United States, compared across the leads, the stimulator and its battery, MRI scanning, brain sensing, programming, remote adjustment and the patient’s own controller. Checked against US labelling in July 2026.
MedtronicAbbottBoston Scientific
The leads placed in the brain
  • SenSight directional lead: 8 contacts, grouped 1-3-3-1, so stimulation can be aimed to one side rather than spread evenly
  • Older 4-contact leads, which do not steer, are still supported
  • Directional leads: 8 contacts, grouped 1-3-3-1
  • Two lengths and two contact spacings to choose from
  • Vercise Cartesia: 8 contacts, directional
  • Vercise Cartesia X and HX: 16 contacts, directional, approved November 2024
  • A 16-contact lead occupies two of the stimulator’s ports, so treating both sides with them needs the 32-contact stimulator
The stimulator, and its battery
  • Percept PC, not rechargeable: Medtronic projects more than five years for a median energy user, and using the sensing features shortens that
  • Percept RC, rechargeable: Medtronic claims at least 15 years of service and warrants it for 15 years in the US
  • Charging Percept RC: up to 9 to 12 days between charges with sensing off, or about 15 minutes a day
  • Infinity 5 and Infinity 7, not rechargeable: in Abbott’s review of its first 5,000 devices in the US, half lasted more than five years
  • Liberta RC, rechargeable: Abbott states that a full charge lasts up to 37 days at nominal settings, about 10 charges a year, and publishes no expected replacement interval
  • Abbott calls Liberta RC the smallest rechargeable DBS stimulator sold in the US at 13.6 cc; its own comparison puts Medtronic’s at 13.8 cc
  • Vercise Genus P8, P16 and P32, not rechargeable: Boston Scientific gives about three to five years for the P16 and publishes no figure for the other two
  • Vercise Genus R16 and R32, rechargeable: warranted for 15 years
  • Charging: 5 to 30 minutes daily, or 30 minutes to 4 hours every one to two weeks
  • The number in each name is how many lead contacts the stimulator can drive
MRI scans
  • 1.5 tesla and 3 tesla scanners
  • Full-body scanning, with no scan-time limit below the radiofrequency levels Medtronic specifies
  • In bipolar mode, stimulation can stay on during the scan
  • 1.5 tesla only — Abbott’s labelling says not to scan at 3 tesla
  • Head, torso and limbs, with up to 30 minutes of active scanning in a session
  • Stimulation is switched off for the scan
  • 1.5 tesla only
  • Full-body scanning
  • Stimulation is switched off for the scan, and a rechargeable stimulator should be fully charged beforehand
Brain sensing and adaptive stimulation
  • BrainSense records brain signals through the same lead that delivers the stimulation
  • BrainSense Adaptive DBS adjusts stimulation moment to moment on its own — approved by the FDA in February 2025, for Parkinson’s disease only
  • It is optional: it needs a usable brain signal, takes extra visits to set up, and does not suit everyone
  • BrainSense Timeline and Events record signals and the patient’s own notes at home, for review at the next visit
No sensing and no adaptive stimulation — the device delivers the settings the team programsNo sensing and no adaptive stimulation — the device delivers the settings the team programs
How stimulation is shaped in clinic
  • Amplitude can be set separately for each contact
  • SureTune 4 shows the lead inside the patient’s own scans to guide programming
  • BrainSense Electrode Identifier suggests a starting contact from the recorded brain signal
  • Stimulation is aimed using the directional contacts
  • MultiStim software alternates between settings to shape the stimulation field
  • Informity software guides directional programming from how the patient responds in clinic rather than from images
  • Multiple independent current control: each contact has its own current source, so current can be divided between contacts
  • STIMVIEW XT shows an estimate of the stimulation field on the patient’s own scans while programming
  • Illumina 3D suggests settings from the areas the clinician marks on those images
Adjusting settings from home
  • Not available — settings are changed in clinic
  • The device still gathers brain-signal and symptom data at home for review at the next visit
  • NeuroSphere Virtual Clinic lets the team change settings during a secure video visit — approved by the FDA in 2021
  • Insurance coverage for these visits is not consistent, and is worth checking before relying on it
  • It does not replace the first programming sessions or periodic in-person review
  • Not available — settings are changed in clinic
  • The patient’s controller can still adjust therapy within the limits the team sets
What the patient carries
  • A Medtronic handset, together with a small communicator that has to be held near the stimulator
  • Adjusts therapy within set limits, switches programs, checks the battery, marks events such as a medication dose, and turns on MRI mode
  • An app, on either an Abbott-supplied phone or a personal iPhone (iPhone 8 or newer)
  • Personal Android phones are not supported
  • The same app carries the video visit
  • Either the Vercise Remote Control 4 handset or the Vercise DBS Controller app
  • The app runs only on a phone Boston Scientific supplies, not a personal one
  • Adjusts therapy within set limits, checks the battery, and turns on MRI mode

All three systems are MR Conditional, which means a scan is permitted only under the conditions set out in the labelling for the exact combination of parts implanted — which is why every scan is arranged through the DBS team. On any rechargeable system, higher stimulation settings mean more frequent charging. Platform names and features also change often, and the team reviews the options as they stand at the time of the decision: the device is chosen together with the patient, based on symptoms, imaging and what matters most day to day.

Travel, exercise and everyday activities

Most daily activities can be resumed after recovery. Patients can travel, exercise, and engage in normal routines. Airport security systems and most household electronics are safe, though patients carry a device identification card and are given guidance on navigating security checkpoints. Certain medical procedures, particularly MRI scans, require coordination with the DBS team, but modern systems are increasingly compatible with imaging when proper protocols are followed.

The emotional adjustment

There are also adjustments that occur beyond the physical. Some patients describe a period of recalibration—getting used to moving differently, trusting their body again, or returning to activities they had gradually given up. For others, there is an emotional component to improvement, particularly after living with chronic symptoms for many years. These changes are normal, and they are part of the broader process of adapting to life with improved function.

A neurologist with a patient during a movement disorders clinic visit, the patient's brain MRI on the screen behind them

What DBS does not do

It is also important to recognize that DBS has limits. It does not stop disease progression, and some symptoms may continue to evolve over time. This is especially true for aspects of Parkinson’s disease such as balance, speech, or cognition. The role of DBS is to improve the symptoms that are most responsive, allowing patients to function better within the broader course of their condition.

A long-term partnership

Long-term success with DBS depends on partnership. The device provides the capability, but the outcome depends on ongoing communication between the patient and the care team. Adjustments, follow-up visits, and honest discussions about symptoms all contribute to maintaining benefit over time.

An advanced practice provider in conversation with a patient in an examination room

Perhaps the most accurate way to think about life with DBS is this: the device fades into the background, and what comes forward is function. Patients spend less time thinking about tremor, stiffness, or fluctuations, and more time focusing on the things that matter to them. The goal is not perfection, but meaningful, sustained improvement—and for many patients, that is exactly what DBS provides.